Related Experiment Video
Updated: Jul 11, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
[Diagnosis and treatment of NSAIDs induced colonic mucosal lesions]
Yuji Amano1, Nobuyuki Moriyama, Yoshikazu Kinoshita
1Division of Endoscopy, Shimane University Hospital.
Abstract:
NSAIDs induced colonic mucosal lesions have been reported to be found in about 3% of chronic NSAIDs users in Japan, suggesting that a particular attention should be paid for the clinical management of NSAIDs users. Differential diagnosis of these lesions is considered to be difficult only by the morphological examination since endoscopic images of the lesions show very various types such as ulcerative and colitis type. Therefore, the diagnostic criteria proposed by Iida et al. play an important role for the confirmation of the clinical diagnosis. Treatment for the lesions is principally the discontinuation of NSAIDs administration since many possibly agents have not been fully evidenced the effect by clinical cohort study. The establishment of the guideline for clinical management of patients with NSAIDs induced colonic mucosal lesions is sincerely required.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.